Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
1958 1
1963 1
1969 1
1970 3
1972 1
1973 1
1977 3
1979 4
1980 2
1981 6
1983 1
1984 4
1985 3
1986 1
1987 8
1988 7
1989 2
1990 10
1991 6
1992 11
1993 10
1994 14
1995 23
1996 20
1997 29
1998 31
1999 30
2000 36
2001 49
2002 62
2003 56
2004 85
2005 111
2006 122
2007 149
2008 213
2009 227
2010 266
2011 326
2012 384
2013 393
2014 506
2015 611
2016 536
2017 628
2018 760
2019 867
2020 1055
2021 1146
2022 1229
2023 1261
2024 1237
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,947 results

Results by year

Filters applied: . Clear all
Page 1
Biotherapies in Uveitis.
Leclercq M, Desbois AC, Domont F, Maalouf G, Touhami S, Cacoub P, Bodaghi B, Saadoun D. Leclercq M, et al. J Clin Med. 2020 Nov 8;9(11):3599. doi: 10.3390/jcm9113599. J Clin Med. 2020. PMID: 33171664 Free PMC article. Review.
Many questions are left unanswered; how long to treat NIU, how to discontinue anti-TNF-alpha agents, what biologic to use in case of anti-TNF-alpha failure? The objective of this review is to present an updated overview of knowledge on the use of biological treatments in …
Many questions are left unanswered; how long to treat NIU, how to discontinue anti-TNF-alpha agents, what biologic to use in case of …
Retraction.
[No authors listed] [No authors listed] J Cell Biochem. 2021 Nov;122 Suppl 1:S51. doi: 10.1002/jcb.30010. Epub 2021 Jun 4. J Cell Biochem. 2021. PMID: 34087021
Retraction: "The circular RNA-NRIP1 plays oncogenic roles by targeting microRNA-505 in the renal carcinoma cell lines," by Zhen Dong, Yidong Liu, Qinghai Wang, Hongyang Wang, Jianlei Ji, Tao Huang, Aashish Khanal, Haitao Niu, Yanwei Cao, J Cell Biochem. 2020; Pages …
Retraction: "The circular RNA-NRIP1 plays oncogenic roles by targeting microRNA-505 in the renal carcinoma cell lines," by Zhen Dong, Yidong …
Microbiome in Immune-Mediated Uveitis.
Rodríguez-Fernández CA, Iglesias MB, de Domingo B, Conde-Pérez K, Vallejo JA, Rodríguez-Martínez L, González-Barcia M, Llorenç V, Mondelo-Garcia C, Poza M, Fernández-Ferreiro A. Rodríguez-Fernández CA, et al. Int J Mol Sci. 2022 Jun 24;23(13):7020. doi: 10.3390/ijms23137020. Int J Mol Sci. 2022. PMID: 35806031 Free PMC article. Review.
The gut microbiome plays an important role in controlling immune response, and dysbiosis has been associated with immune-mediated diseases such as non-infectious uveitis (NIU). In this review, we gather the published evidence, both in the pre-clinical and clinical studies, …
The gut microbiome plays an important role in controlling immune response, and dysbiosis has been associated with immune-mediated diseases s …
Neurodegeneration and regeneration.
Niu J. Niu J. J Neurosci Res. 2017 Aug;95(8):1525-1527. doi: 10.1002/jnr.24069. Epub 2017 May 9. J Neurosci Res. 2017. PMID: 28485030 Free PMC article. No abstract available.
Intraocular therapy in noninfectious uveitis.
Modugno RL, Testi I, Pavesio C. Modugno RL, et al. J Ophthalmic Inflamm Infect. 2021 Oct 10;11(1):37. doi: 10.1186/s12348-021-00267-x. J Ophthalmic Inflamm Infect. 2021. PMID: 34632541 Free PMC article. Review.
Systemic corticosteroids and immunosuppressant agents are the mainstay of therapy for non-infectious uveitis (NIU). However, the risks associated with systemic administration and the need of delivering an effective and safe anti-inflammatory treatment targeted to the site …
Systemic corticosteroids and immunosuppressant agents are the mainstay of therapy for non-infectious uveitis (NIU). However, the risk …
On Closed-Shell Interactions, Polar Covalences, d Shell Holes, and Direct Images of Orbitals: The Case of Cuprite Discussions with Professors and Doctors G. von Bunau, B. Engelen, H. D. Lutz, J. Niu-Schwarz, and A. Pfitzner (Siegen, Germany), R. Hoffmann (Ithaka, NY, USA), C. J. Humphreys (Cambridge, UK), A. Kirfel (Bonn, Germany), T. Lippman and J. Schneider (Hamburg, Germany), K. Schwarz (Vienna, Austria), M. Spackman (Armidale, Australia), J. C. H. Spence, M. O'Keefe and J. M. Zuo (Tempe AZ, USA), and financial support by Deutsche Forschungsgemeinschaft (DFG) and by Fonds der Chemischen Industrie (FCI) are all gratefully acknowledged.
Wang SG, Schwarz WH. Wang SG, et al. Angew Chem Int Ed Engl. 2000 May 15;39(10):1757-1761. doi: 10.1002/(sici)1521-3773(20000515)39:10<1757::aid-anie1757>3.0.co;2-i. Angew Chem Int Ed Engl. 2000. PMID: 10934353 No abstract available.
Corrigendum to Kao, C.-C., Chiu, H.-L., Liu, D., Chan, P.-T., Tseng, I.-J., Chen, R., Niu, S.-F., Chou,K.-R., 2018. Effect of interactive cognitive motor training on gait and balance among older adults: A randomized controlled trial. International Journal of Nursing Studies 82, 121-128.
Chou KR. Chou KR. Int J Nurs Stud. 2020 Nov;111:103777. doi: 10.1016/j.ijnurstu.2020.103777. Epub 2020 Oct 3. Int J Nurs Stud. 2020. PMID: 33023740 No abstract available.
The Humira in Ocular Inflammations Taper (HOT) Study.
Pichi F, Smith SD, Goldstein DA, Baddar D, Gerges TKA, Janetos TM, Ruiz-Cruz M, Elena Concha-Del-Río L, Maruyama K, Carina Ten Berge J, Rombach SM, Cimino L, Bolletta E, Miserocchi E, Scandale P, Serafino M, Camicione P, Androudi S, Gonzalez-Lopez JJ, Lim LL, Singh N, Gupta V, Gupta N, Amer R, Dodds EM, Inchauspe S, Munk MR, Donicova E, Carreño E, Takeuchi M, Chee SP, Chew MC, Agarwal A, Schlaen A, Gómez RA, Couto CA, Khairallah M, Neri P. Pichi F, et al. Am J Ophthalmol. 2024 Feb;258:87-98. doi: 10.1016/j.ajo.2023.09.012. Epub 2023 Sep 19. Am J Ophthalmol. 2024. PMID: 37734639 Free article.
PURPOSE: To assess factors that impact the risk of relapse in patients with noninfectious uveitis (NIU) who undergo adalimumab tapering after achieving remission. DESIGN: Retrospective study. METHODS: In this multicenter study, patients with NIU were treated with ad …
PURPOSE: To assess factors that impact the risk of relapse in patients with noninfectious uveitis (NIU) who undergo adalimumab taperi …
10,947 results
You have reached the last available page of results. Please see the User Guide for more information.